Xylem Statistics

Total Valuation

Xylem has a market cap or net worth of EUR 28.25 billion. The enterprise value is 29.34 billion.

Market Cap	28.25B
Enterprise Value	29.34B

Important Dates

The next estimated earnings date is Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	Nov 26, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+19.87%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	241.16M

Valuation Ratios

The trailing PE ratio is 37.96.

PE Ratio	37.96
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	46.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.55, with an EV/FCF ratio of 39.52.

EV / Earnings	39.42
EV / Sales	3.58
EV / EBITDA	16.55
EV / EBIT	26.67
EV / FCF	39.52

Financial Position

The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.20.

Current Ratio	1.96
Quick Ratio	1.31
Debt / Equity	0.20
Debt / EBITDA	1.15
Debt / FCF	2.54
Interest Coverage	23.10

Financial Efficiency

Return on equity (ROE) is 8.08% and return on invested capital (ROIC) is 5.66%.

Return on Equity (ROE)	8.08%
Return on Assets (ROA)	4.43%
Return on Capital (ROIC)	5.66%
Revenue Per Employee	328,389
Profits Per Employee	32,356
Employee Count	23,000
Asset Turnover	0.53
Inventory Turnover	4.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.68% in the last 52 weeks. The beta is 1.05, so Xylem's price volatility has been similar to the market average.

Beta (5Y)	1.05
52-Week Price Change	+14.68%
50-Day Moving Average	116.21
200-Day Moving Average	122.05
Relative Strength Index (RSI)	50.92
Average Volume (20 Days)	73

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.57

Income Statement

In the last 12 months, Xylem had revenue of EUR 7.55 billion and earned 744.18 million in profits. Earnings per share was 3.06.

Revenue	7.55B
Gross Profit	2.79B
Operating Income	1.01B
Pretax Income	826.67M
Net Income	744.18M
EBITDA	1.51B
EBIT	1.01B
Earnings Per Share (EPS)	3.06

Full Income Statement

Balance Sheet

The company has 886.74 million in cash and 1.89 billion in debt, giving a net cash position of -998.81 million.

Cash & Cash Equivalents	886.74M
Total Debt	1.89B
Net Cash	-998.81M
Net Cash Per Share	n/a
Equity (Book Value)	9.50B
Book Value Per Share	39.09
Working Capital	1.76B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.02 billion and capital expenditures -282.43 million, giving a free cash flow of 742.38 million.

Operating Cash Flow	1.02B
Capital Expenditures	-282.43M
Free Cash Flow	742.38M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 36.93%, with operating and profit margins of 13.44% and 9.85%.

Gross Margin	36.93%
Operating Margin	13.44%
Pretax Margin	10.94%
Profit Margin	9.85%
EBITDA Margin	20.05%
EBIT Margin	13.44%
FCF Margin	9.83%

Dividends & Yields

This stock pays an annual dividend of 1.33, which amounts to a dividend yield of 1.14%.

Dividend Per Share	1.33
Dividend Yield	1.14%
Dividend Growth (YoY)	9.00%
Years of Dividend Growth	6
Payout Ratio	41.33%
Buyback Yield	-19.87%
Shareholder Yield	-18.72%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Xylem has an Altman Z-Score of 4.43.

Altman Z-Score	4.43
Piotroski F-Score	n/a